Recently, a collaborative team from PUMCH's Department of Hematology, led by Chief Physician Dr. Zhang Wei, and the Department of Dermatology, led by Chief Physician Dr. Liu Jie, published their latest research findings in the internationally prestigious journ...

Recently, a prospective, multicenter, randomized controlled study led by Professor Xiang Yang, Director of the Gynecological Oncology Center at PUMCH, was published in the internationally renowned journal Annals of Oncology. The study compared two first-line s...

The research team led by Director Han Xiaohong and Assistant Director Zheng Xin of the Clinical Pharmacology Research Center at PUMCH, in collaboration with the team led by Deputy Director Ma Mingsheng of Pediatrics and researchers from China University of Min...

On the afternoon of July 11, 2025, XH-02 injection, a proprietary mRNA drug developed by PUMCH, was successfully administered to the first adult patient with hypoparathyroidism (HP). XH-02 injection is the world's first mRNA drug for adult hypoparathyroidism, ...